4th Annual CAR-TCR Summit

The CAR-TCR Summit will be held from September 4 to 7, 2018 in Boston, Massachusetts.

André Choulika, Ph.D., Chairman and Chief Executive Officer of Cellectis, and David Sourdive, Ph.D., Executive Vice President Technical Operations, to take part in this event.

Dr Choulika will participate in a panel of discussion entitled "Next Generation CAR-TCR Therapies: Executives Leaders' Fireside Chat" on September the 6th from 9:30 AM to 10:30 AM. He will then participate in another panel entitled "What are the Pros and Cons of the Various Gene Editing Technologies for CAR-TCR Therapies" from 2:35 PM to 3:10 PM.

Dr Sourdive will participate in a Deep Dive session entitled "How Will Gene Editing Take Off-The-Shelf Allogeneic Cell Therapies to the Next Stage in the Future?" on September the 4th from 9:00 AM to 11:00 AM. He will then participate in a panel of discussion entitled "How can we Create an Allogeneic, Virus Free Manufacturing Process?" on September the 6th from 2:35 PM to 3:10 PM.